Cargando…
Refractory hypokalemia caused by cetuximab with advanced colorectal cancer patients: the case series and literature review
Cetuximab is the first-line treatment for advanced metastatic colon cancer. But cetuximab can cause electrolyte disturbances, including hypomagnesemia and hypokalemia. Among them, hypokalemia is often caused by hypomagnesemia, not directly caused by cetuximab. This article reports two cases of refra...
Autores principales: | Chen, Yun-Wang, Yang, Min, Wang, Ming-Xing, Jiang, Jia-Hong, Jiang, Ding-Yi, Chen, Zhe-Ling, Yang, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670339/ https://www.ncbi.nlm.nih.gov/pubmed/34419963 http://dx.doi.org/10.1097/CAD.0000000000001212 |
Ejemplares similares
-
Hypokalemia-Induced Arrhythmia: A Case Series and Literature Review
por: Thu Kyaw, May, et al.
Publicado: (2022) -
Refractory Hypokalemia While Weaning Off Bypass
por: Soori, Rashmi, et al.
Publicado: (2018) -
Acute aortic dissection caused by fruquintinib for metastatic colorectal cancer—a case report and literature review
por: Deng, Ya-Ya, et al.
Publicado: (2023) -
A Rare Case of Levetiracetam-Induced Refractory Hypokalemia
por: Coughlin, Paige, et al.
Publicado: (2022) -
Diabetic Ketoacidosis With Refractory Hypokalemia Leading to Cardiac Arrest
por: Grout, Sarah, et al.
Publicado: (2022)